The human myoepithelial cell displays a multifaceted anti-angiogenic phenotype

Oncogene

Volumn 19, Issue 31, 2000, Pages 3449-3459

  Nguyen, Mai ^a   Lee, Maggie C ^a   Wang, Jing Liang ^a   Tomlinson, James S ^a   Shao, Zhi Ming ^a   Alpaugh, Mary L ^a   Barsky, Sanford H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Angiogenic factors; Angiogenic inhibitors; Factor 1; Hypoxia inducible; Thrombospondin 1

Indexed keywords

ANGIOGENESIS INHIBITOR; FIBROBLAST GROWTH FACTOR RECEPTOR; MESSENGER RNA; NITRIC OXIDE SYNTHASE; THROMBOSPONDIN 1; TISSUE INHIBITOR OF METALLOPROTEINASE 1; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CELL DEATH; CELL LINE; CELL PROLIFERATION; CHEMOTAXIS; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HYPOXIA; METASTASIS; MYOEPITHELIUM CELL; PRIORITY JOURNAL; XENOGRAFT;

EID: 0034691828     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1203677     Document Type: Article

References (31)

1. Alpaugh ML, Tomlinson JS, Shao ZM and Barsky SH. (1999). Cancer Res., 59, 5079-5084.
2. Bagavandoss P and Wilkes JW. (1990). Biochem. Biophys. Res. Commun., 170, 867-872.
3. Cavenee WK. (1993). J. Clin. Invest., 91, 3.
4. Clapp C, Martial JA, Guzman RC, Rentier-Delrue F and Weiner RI. (1993). Endocrinology 133, 1292-1299.
5. Cornil I, Theodorescu D, Man S, Herlyn M, Jambrosic J and Kerbel RS. (1991). Proc Natl. Acad. Sci. USA, 88, 6028-6032.
6. Dawson DW, Pearce SFA, Zhong R, Silverstein RL, Frazier WA and Bouck NP. (1997). J. Cell Biol., 138, 707-717.
7. Folkman J. (1990). J. Natl. Cancer Inst., 82, 1-3.
8. Folkman J. (1995a). N. Engl. J. Med., 333, 1757-1763.
9. Folkman J. (1995b). The Molecular Basis of Cancer, ed. Mendelsohn J, Howley PM, Israel MA and Liotta LA. pp. 206-232.
10. Folkman J and Klagsbrun M. (1987). Science, 235, 442-447.
11. Fridman R, Kibbey MC, Royce LS, Zain M, Sweeney TM, Jicha DL, Yannelli JR, Martin GR and Kleinman HK. (1991). J. Natl. Cancer Inst., 83, 769-774.
12. Hanahan D and Folkman J. (1996). Cell, 86, 353-364.
13. Langone JJ. (1982). Adv Immunol., 32, 157-252.
14. Liotta LA, Steeg PS and Stetler-Stevenson WG. (1991). Cell, 64, 327-336.
15. Namiki A, Brogi E, Kearney M, Kim EA, Wu T, Couffinhal T, Varticovski L and Isner JM. (1995). J. Biol. Chem., 270, 31189-31195.
16. Nguyen M, Strubel NA and Bischoff J. (1993). Nature, 365, 267-269.
17. O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR and Folkman J. (1997). Cell, 88, 277-285.
18. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH and Folkman J. (1994). Cell, 79, 315-328.
19. O'Reilly MS, Pirie-Shepherd S, Lane WS and Folkman J. (1999). Science, 285, 1926-1928.
20. Safarians S, Sternlicht MD, Freiman CJ, Huaman JA and Barsky SH. (1996). Int. J. Cancer, 66, 151-158.
21. Shao ZM, Nguyen M, Alpaugh ML, O'Connell JT and Barsky SH. (1998). Exp. Cell Res., 241, 394-403.
22. Sternlicht MD, Kedeshian P, Shao ZM, Safarians S and Barsky SH. (1997). Clin. Cancer Res., 3, 1949-1958.
23. Sternlicht MD, Safarians S, Calcaterra TC and Barsky SH. (1996b). In Vitro Cell. Dev. Biol., 32, 550-563.
24. Sternlicht MD, Safarians S, Rivera SP and Barsky SH. (1996a). Lab. Invest., 74, 781-796.
25. Tobacman JK. (1997). Cancer Res., 57, 2823-2826.
26. Varia MA, Calkins-Adams DP, Rinker LH, Kennedy AS, Novotny DB, Fowler WC and Raleigh JA. (1998). Gynecol. Oncol., 71, 270-277.
27. Weidner N, Semple JP, Welch WR and Folkman J. (1991). N. Engl. J. Med., 324, 1-8.
28. Weinstat-Saslow DL, Zabrenetzky VS, VanHoutte K, Frazier WA, Roberts DD and Steeg PS. (1994). Cancer Res., 54, 6504-6511.
29. Xiao G, Liu YE, Gentz R, Sang QA, Ni J, Goldberg ID and Shi YE. (1999). Proc. Natl. Acad. Sci. USA, 96, 3700-3705.
30. Zhang M, Volpert O, Shi YH and Bouck N. (2000). Nature Med., 6, 196-199.
31. Zou Z, Anisowicz A, Hendrix MJC, Thor A, Neveu M, Sheng S, Rafidid K, Seftor E and Sager R. (1994). Science, 263, 526-529.